All In Biotech

Drug Trial Radar · NCT01092754

Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Optimark (Gadoversetamide) in Pediatric Patients

An Open-Label, Multicenter, Phase 4 Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Optimark(R) in Pediatric Patients (2-11 & 12-18 Yrs) Referred for Contrast-Enhanced MRI

Last checked: Nov 20, 2026Latest source record: Aug 1, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

100

Actual

Start

May 2002

Primary completion

Dec 2003

Study completion Dec 2003

Sponsor

Lead sponsor
GuerbetIndustry
Sponsor type
Industry
First posted
Mar 25, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Diagnostic
Who can join
All sexes, from 2 years, up to 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study is to characterize the safety, efficacy and pharmacokinetic profiles of Optimark at the standard clinical dose of 0.1 mmol/kg in the pediatric patient population.

Conditions

  • Pathological Processes

Interventions

  • MRIProcedure

    contrast enhanced MRI

  • MRIProcedure

    contrast enhanced MRI

  • GadoversetamideDrug

    Subjects will receive a single dose of Optimark(0.1 mmol/kg)as a bolus thru a peripheral IV line at 1-2 mL/sec followed by a saline flush during their medically necessary MRI .

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Assess efficacy by analyzing the clinical diagnosis, degree of confidence in diagnosis and level of conspicuity of lesions.Time frame: Immediately before and immediately after Optimark dosing

Locations

12 sites in 1 country. Site status is shown where the registry gives one.

  • Arkansas Childrens Hospital

    Little Rock, Arkansas

  • Childrens Hospital and Health Center

    San Diego, California

  • Miami Children's Hospital

    Miami, Florida

  • Children's Mercy Hospitals and clinics

    Kansas City, Kansas

  • Louisiana State University Sciences Center- Shreveport

    Shreveport, Louisiana

  • Childrens Hospital of Michigan

    Detroit, Michigan

  • Cardinal Glennon Childrens Hospital

    St Louis, Missouri

  • St. Louis Childrens Hospital

    St Louis, Missouri

  • Cincinnati Children's Hospital Medical Center

    Cincinnati, Ohio

  • University Hospitals of Cleveland

    Cleveland, Ohio

  • The Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania

  • Texas Childrens Hospital

    Houston, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.